Definition: "An ergogenic aid is any substance or phenomenon that enhances performance "
|
|
||||||||
22.11.2013 |
|
Oxymetholone breaks down fat and builds up muscle
In the steroids scene oxymetholone is known as a pretty risky oral anabolic steroid that can give users extra muscle mass and strength, but alos may lead to moisture retention and fat mass growth. An American study in which elderly men were given 50 or 100 mg oxymetholone every day for 12 weeks confirms this reputation. But not when it comes to the effect on fat mass.
Study
The researchers divided their subjects, all healthy men aged between 65 and 80, into three groups. One group was given a placebo; the second took 50 mg and the third group 100 mg oxymetholone daily. The men consumed about 1 g protein per kg bodyweight per day and did not do any weight training.
Results
![]() ![]()
The maximal strength that the men managed to develop when doing chest-press, lat-pulldown and leg press exercises increased by several tens of percent among the oxymetholone takers.
Doctors monitored the men during the experiment. They only found it necessary to intervene in the case of one man whose ALT enzyme level rose dangerously high. The man, who had taken 100 mg oxymetholone, admitted that he had drunk four glasses of wine before the doctors took a blood sample from him. After a week without alcohol, his blood levels had returned to normal. The incident confirms what many people in doping circles know from experience. Alcohol and oxymetholone are not a good combination for many users.
Nevertheless, other things happened to the oxymetholone takers that are a slight cause for concern. Their ALT and AST levels rose slightly and their HDL levels went down. The effects were relatively small, but were statistically significant.
Conclusion
"The study leaves a number of issues unresolved, including the optimal formulation of androgen for supplementation in this age group, the benefits and risks of longer periods of therapy, the durability of outcomes associated with intermittent therapy, the question of whether measures of visceral adipose tissue and markers of atherosclerosis are improved, and the question of whether similar beneficial effects can be achieved in older women", the researchers write.
Source:
More:
|
|